GALECTIN THERAPEUTICS INC — Director's Dealing 2014

Feb 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2014-01-31

Reporting Person: Prelack Steven (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-31	Common Stock	M	667	$.72	Acquired	3603	Direct
2014-01-31	Common Stock	M	83334	$1.20	Acquired	86937	Direct
2014-01-31	Common Stock	M	9260	$6.48	Acquired	96197	Direct
2014-01-31	Common Stock	M	8475	$7.08	Acquired	104672	Direct
2014-01-31	Common Stock	M	6269	$3.59	Acquired	110941	Direct
2014-01-31	Common Stock	F	17722	$13.71	Disposed	93219	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-31	Stock Option (right to buy)	$.72	M	667	Disposed	2014-02-08	Common Stock (667)	Direct
2014-01-31	Stock Option (right to buy)	$1.20	M	83334	Disposed	2014-02-25	Common Stock (83334)	Direct
2014-01-31	Stock Option (right to buy)	$6.48	M	9260	Disposed	2016-03-24	Common Stock (9260)	Direct
2014-01-31	Stock Option (right to buy)	$7.08	M	8475	Disposed	2021-06-28	Common Stock (8475)	Direct
2014-01-31	Stock Option (right to buy)	$3.59	M	6269	Disposed	2023-03-28	Common Stock (6269)	Direct

Footnotes

F1: This option was previously reported as covering 4,000 shares at an exercise price of $0.12 per share, but was adjusted to reflect the 1-for-6 reverse stock split that occurred in March 2012.

F2: Stock Option grant, vested as follows: (i) 50% on February 25, 2010; (ii) 25% on May 25, 2010; (iii) 12.5% on August 25, 2010; (iv) 6.25% on November 25, 2010; and (v) 6.25% on February 25, 2011.

F3: This option was previously reported as covering 500,000 shares at an exercise price of $0.2 per share, but was adjusted to reflect the 1-for-6 reverse stock split that occurred in March 2012.

F4: This option was previously reported as covering 55,556 shares at an exercise price of $1.08 per share, but was adjusted to reflect the 1-for-6 reverse stock split that occurred in March 2012.

F5: The option vests in eight equal installments beginning May 12, 2011.

F6: This option was previously reported as covering 50,848 shares at an exercise price of $1.18 per share, but was adjusted to reflect the 1-for-6 reverse stock split that occurred in March 2012.

F7: The option vests as to one-eighth of the shares on June 28, 2011 and thereafter quarterly in seven equal installments beginning August 12, 2011.

F8: The option vests quarterly in eight equal installments beginning on May 12, 2013.

F9: Represents shares forfeited in satisfaction of exercise price of vested options.